Herbicide-resistant weeds challenge producers and agrochemical companies with a vexing issue that some refer to as a ‘wicked ...
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses ...
4h
News-Medical.Net on MSNTraditional Chinese medicine targets cholesterol metabolism for cancer treatmentResearchers explore how natural compounds in traditional Chinese medicine can modulate cholesterol metabolism to combat ...
7h
News-Medical.Net on MSNCan natural supplements backfire? Review explains how and whyA new review uncovers how common natural supplements can both protect and endanger health, depending on dose, duration, and ...
The FDA has approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in ...
Qfitlia (fitusiran), an siRNA drug to treat the frequency of bleeding episodes in adult and pediatric patients with hemophilia A or B, gets FDA approval.
Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.
Silver Spring, Maryland Monday, March 31, 2025, 09:00 Hrs [IST] ...
IDEAYA Biosciences, Inc. , a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that the U.S. Food and Drug Administration (FDA) ...
AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results